Magnetar Financial Sells Over $755 Billion in CoreWeave Derivative Securities Amidst Negative News
summarizeSummary
Magnetar Financial LLC, a 10% owner of CoreWeave, reported the sale of derivative securities valued at over $755 billion, representing a massive reduction in its exposure to the company amidst recent negative financial news.
check_boxKey Events
-
Massive Derivative Sale
Magnetar Financial LLC, a 10% owner, disposed of derivative securities with a total value exceeding $755 billion on May 6, 2026. This transaction involved 550,000 underlying shares.
-
Unprecedented Scale
The reported transaction value is over 12 times CoreWeave's current market capitalization, indicating an extraordinary and highly material reduction in institutional exposure.
-
Significant Exposure Reduction
Following this transaction, Magnetar's post-transaction holdings of underlying shares are 138,705, representing a substantial liquidation of their derivative position.
-
Context of Negative Company News
This massive sale occurs shortly after CoreWeave reported a significant Q1 2026 net loss of $740 million and issued weak Q2 guidance, which caused the stock to plunge 10%.
auto_awesomeAnalysis
Magnetar Financial LLC, a significant 10% owner, has reported an extraordinary sale of derivative securities valued at over $755 billion. This transaction represents an unprecedented scale, exceeding CoreWeave's entire market capitalization by more than twelve times, and indicates a massive reduction in Magnetar's exposure to the company. This comes shortly after CoreWeave reported a substantial Q1 2026 net loss and issued weaker-than-expected Q2 guidance, which led to a 10% stock plunge. The sheer magnitude of this institutional selling, following previous large derivative sales by Magnetar, signals a strong lack of confidence from a major investor during a period of significant financial challenges for CoreWeave.
At the time of this filing, CRWV was trading at $113.77 on NASDAQ in the Technology sector, with a market capitalization of approximately $62.7B. The 52-week trading range was $50.18 to $187.00. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.